Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 973 K571 K391 K913 K 2.85 M Research & development ———— — Operating income 17.65 M19.9 M19.92 M20.54 M 78.02 M Non-Operating Income, Total 449 K451 K462 K20.16 M 21.52 M Interest expense, net of interest capitalized 13.71 M13.7 M13.14 M12.82 M 53.38 M Non-Operating Income, excl. Interest Expenses -13.27 M-13.25 M-12.68 M7.33 M -31.86 M Unusual income/expense ———— — Pretax income 7.03 M8.78 M8.73 M8.29 M 32.83 M Equity in earnings ———— — Taxes 1.06 M2.04 M1.6 M1.96 M 6.66 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 5.96 M6.74 M7.14 M6.33 M 26.17 M Discontinued operations ———— — Net income 5.96 M6.74 M7.14 M6.33 M 26.17 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 5.96 M6.74 M7.14 M6.33 M 26.17 M Basic earnings per share (Basic EPS) 0.580.570.60.53 2.28 Diluted earnings per share (Diluted EPS) 0.570.540.580.51 2.2 Average basic shares outstanding 10.28 M11.94 M11.13 M11.98 M — Diluted shares outstanding 10.61 M12.33 M11.52 M12.44 M — EBITDA 4.02 M6.3 M6.84 M7.84 M 25.01 M EBIT 3.65 M5.91 M6.45 M7.44 M 23.45 M Cost of revenue 752 K653 K1.16 M382 K 2.95 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 369 K392 K390 K406 K 1.56 M